戻る Agenda
FDA Enforcement Update: Advertising and Promotion
Session Chair(s)
Wayne Pines
President, Health Care
United States
FDA enforcement actions and policy guidances need to be understood by every company because they reflect FDA's priorities and concerns in regulating advertising and promotion. In this forum, an FDA professional and a representative from industry will examine the latest agency enforcement actions and policies and what they mean.
Learning Objective : Describe the latest FDA enforcement actions and policy initiatives in the area of advertising and promotion; Explain what the enforcement actions reflect about FDA policies and priorities.
Speaker(s)
CDER Perspective
Thomas W. Abrams, MBA, RPH
Former FDA, United States
Retired, Director, Office of Prescription Drug Promotion, OMP, CDER
Industry Perspective
Pamela M. Williamson, MBA, RAC
Genzyme Corporation, A Sanofi Company, United States
Senior Vice President, Global Head, Regulatory Affairs and Compliance